{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiem6i2up4mnbbucksi6ujoak5drwcl5fuidztoumscmopxisn6ihu",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mhvk4hov5ml2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibjmlqveupdmz373ndsmjigz7yf4n2xxjr7abx3jkih7fjq4beexy"
    },
    "mimeType": "image/jpeg",
    "size": 584237
  },
  "path": "/news/2026-03-zr-fusion-protein-sways-brain.html",
  "publishedAt": "2026-03-25T12:00:43.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A team of researchers at Baylor College of Medicine, St. Jude Children's Research Hospital, Texas Children's Hospital and collaborating institutions reveal in the journal Nature a novel mechanism that drives the development of pediatric supratentorial ependymoma (EPN), the third most common pediatric brain tumor. The findings suggest potential new approaches to treat these aggressive and chemo-resistant tumors.",
  "title": "ZR fusion protein sways normal brain cell development toward cancer growth, study reveals"
}